Seattle、WAにおける血液がんの臨床試験
Seattleとその周辺地域（約30マイル以内）の拠点で、血液がんに関する18件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- 他1件
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
被験者募集中第1/2相
- Fred Hutchinson Cancer Research Center, Seattle
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
被験者募集中第3相
- Fred Hutchinson Cancer Research Center, Seattle
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
被験者募集中観察研究
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
被験者募集中第1相
- University of Washington, Seattle
Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
被験者募集中健康なボランティア歓迎
- Fred Hutch/University of Washington Cancer Consortium, Seattle
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
被験者募集中第2相
- Fred Hutchinson Cancer Center, Seattle
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
被験者募集中観察研究
- Fred Hutchinson Cancer Research Center, Seattle
IVIG for Infection Prevention After CAR-T-Cell Therapy
被験者募集中第2相
- Fred Hutch/University of Washington Cancer Consortium, Seattle
211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
被験者募集中第1/2相
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
被験者募集中観察研究
- Seattle Childrens Hospital, Seattle
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
被験者募集中第1/2相
- University of Washington Medical Center, Seattle
Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
被験者募集中第2相健康なボランティア歓迎
- Fred Hutchinson Cancer Centre, Seattle
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
被験者募集中観察研究
- Swedish Cancer Institute, Seattle
PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma
被験者募集中
- University of Washington, Seattle
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
被験者募集中第1相
- Fred Hutchinson Cancer Center, Seattle
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
被験者募集中第1相
- Seattle Children's Hospital, Seattle
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
被験者募集中第1相
- Fred Hutchinson Cancer Center, Seattle
他の都市における血液がんの試験
- Houston, TX46件の研究
- New York City, NY26件の研究
- Boston, MA25件の研究
- Washington, DC19件の研究
- Baltimore, MD18件の研究
- Los Angeles, CA17件の研究
- Durham, NC16件の研究
- Chicago, IL15件の研究
- Philadelphia, PA14件の研究
- Nashville, TN13件の研究
- Atlanta, GA13件の研究
- Edison, NJ13件の研究
Seattleにおける他の研究
- 非小細胞肺癌53件の研究
- がん（全種類）49件の研究
- 前立腺がん42件の研究
- 急性骨髄性白血病40件の研究
- 乳がん39件の研究
- 転移性癌39件の研究
- 大腸癌34件の研究
- 肺がん33件の研究
- 卵巣がん30件の研究
- 多発性骨髄腫22件の研究
- 骨髄異形成症候群21件の研究
- 急性リンパ性白血病21件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。